S3I-1757

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameS3I-1757
Drug Alias NameSTAT3 dimerization inhibitor (H Lee Moffitt Cancer Center and Research Institute/University of South Florida)S3I-1757
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesH Lee Moffitt Cancer Center & Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of South FloridaH Lee Moffitt Cancer Center & Research Institute
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A